Chemicalinfo Chemlink Pharm-Chem Net

Chemical Pharmaceutical News

美国FDA的委员会同意Asteilas / Cardiome的心律失常药 Vernakalan

美国FDA的委员会同意Asteilas / Cardiome的心律失常药Vernakalan美国FDA心血管和肾脏药物顾问委员会以6:2同意Astellas/Cardiome Pharma新型抗心律失常药Kynapid(vernakalant盐酸注射液)(I)用于房颤(AF)的快速复律。(I)是混合的钾和钠通道阻断剂。两公司申请用于持续7天或以下的AF转为窦性心律的许可证。建议的剂量是开始以3mg/kg静脉滴注1O分钟,如在滴注完毕后15分钟内没有复律,则再给予2mg/kg,在1O分钟内滴注。疗...

GSK Submits TYVERB(R)/TYKERB(R) (lapatinib) for First-Line Treatment of Metastatic...

GSK Submits TYVERB(R)/TYKERB(R) (lapatinib) for First-Line Treatment ofMetastatic Breast Cancer in Europe, USLONDON and PHILADELPHIA, April 1, /PRNewswire-FirstCall/ -- GlaxoSmithKline(NYSE: GSK) today announced the submission of two simultaneous reg...

临床研究证明: 达沙替尼(Dasatinib/Sprycel)治疗白血病是一种安全有效药物

达沙替尼(Dasatinib/Sprycel),用于已经治疗,包括甲磺酸伊马替尼(Imatinibmesylate/Gleevec)耐药或不能耐受的慢性骨髓性白血病所有病期(慢性期、加速期、淋巴系细胞急变期和髓细胞急变期)的成人患者。同 ...

Zilmax (Zilpaterol hydrochloride) Offers Extended Marketing Window For Cattle Feeders

Zilmax (Zilpaterol hydrochloride) Offers Extended Marketing Window For Cattle Feeders DE SOTO, Kan. (Feb. 2, 2009) — A few days of market fluctuations can have dramatic effects on a feedyard’s bottom line, which means marketing flexi...

FDA Approves Gleevec (Imatinib mesylate) to Prevent Recurrence of Rare Gastrointestinal Cancer

FDA News FOR IMMEDIATE RELEASE December 19, 2008 Media Inquiries: Karen Riley, 301-796-4674 Consumer Inquiries: 888-INFO-FDA ...

2009年国际一线药企重点研发产品时间表

2009年国际一线药企重点研发产品时间表2009/1/9/09:38 来源:医药网肿瘤:针对前列腺、肾脏等靶标     据报道,目前制药业的研发线中有750只抗肿瘤药物。这其中的许多药物是不可能上市的,但下面的这些抗肿瘤药物不能让人忽视:     第一只是CougarBiotechnology公司用于治疗前列腺癌的口服药物阿比特龙(Abiraterone)。许多研究显示,前列腺癌能自身产生睾酮,而阿比特龙能抑制涉及到睾酮产生的酶CYP1...

FDA Approves Gleevec (Imatinib mesylate) for Gastrointestinal Stromal Tumor

FDA核准Gleevec(Imatinib mesylate)作为肠胃道基质肿瘤的治疗 作者:Laurie Barclay, MD 出处:WebMD 医学新闻   December 23, 2008 — 12月19日,美国食品药物管理局(FDA)核准i...

FDA Approved Drugs During 2008

FDA Approved Drugs During 2008The FDA's drug approval process is one that has critics on both sides. The drugmakers often complain that the agency is too slow and too cautious. Critics of the drugmakers often feel that the companies just aren't pumpi...

新药物或可增强甲磺酸伊马替尼抗白血病效果 (Potential New Way To Make A Good Anti-leukemia Drug Imatinib mesylate Even Better)

新药物或可增强伊马替尼抗白血病效果Potential New Way To Make A Good Anti-leukemia Drug Even Betterhttp://www.sciencedaily.com/releases/2008/10/081020093402.htmScienceDaily (Oct. 21, 2008) — A recently identified cancer-causing protein makes the anti-leukemia dru...

两部门通知: 11月1日起将提高部分商品出口退税率

 两部门通知: 11月1日起将提高部分商品出口退税率2008年10月21日   来源:财政部网站近日,经国务院批准,财政部、国家税务总局发出《关于提高部分商品出口退税率的通知》,明确从2008年11月1日起,适当调高部分劳动密集型和高技术含量、高附加值商品的出口退税率。具体为:将部分纺织品、服装、玩具出口退税率提高到14%;将日用及艺术陶瓷出口退税率提高到11%;将部分塑料制品出口退税率提高到9%;将部分家具出口退税率分别提高到11%、13%;将艾滋病药物、基因重组人胰岛素冻干粉、黄胶...
分页:[«]1[2][3][4][5][6][7][8][9][»]

Powered By Z-Blog 1.7 Laputa Build 70216

Copyright 2005-2009 Your WebSite. Some Rights Reserved.